Express Pharma

Eisai files for approval of Alzheimer’s drug in Europe

The drug, developed in partnership with Biogen, is an antibody that has been shown to remove sticky deposits of a protein called amyloid beta from the brains of those in the early stages of the mind-wasting disease

1 119